Recombinant CD4 (Cedelizumab Biosimilar) antibody
The Humanized Chimeric anti-CD4 (Cedelizumab Biosimilar) antibody is suitable to detect CD4 (Cedelizumab Biosimilar) in samples from Human.
Catalog No. ABIN7597582
$401.14
Plus shipping costs $50.00, if applicable $20.00 dry ice
Shipping to:
United States
Delivery in 12 to 15 Business Days
Quick Overview for Recombinant CD4 (Cedelizumab Biosimilar) antibody (ABIN7597582)
Target
CD4 (Cedelizumab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Human
Host
Humanized
Clonality
Chimeric
Grade
Research Grade
-
-
Expression System
- Mammalian cells
-
Purpose
- Research Grade Cedelizumab Biosimilar Antibody
-
Specificity
- T-cell surface antigen T4/Leu-3, T-cell surface glycoprotein CD4, CD4
-
Purification
- Protein A or G purified from cell culture supernatant.
-
Purity
- >95 % by SDS-PAGE.
-
Isotype
- IgG4 kappa
-
-
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- 0.01M PBS, pH 7.4.
-
Storage
- 4 °C,-20 °C,-80 °C
-
Storage Comment
- Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.
-
Expiry Date
- 12 months
-
-
- CD4 (Cedelizumab Biosimilar)
-
Alternative Name
- Cedelizumab Biosimilar
-
Target Type
- Biosimilar
-
Background
- T-cell surface antigen T4/Leu-3, T-cell surface glycoprotein CD4, CD4
-
UniProt
- P01730
-
CAS-No
- 156586-90-2
Target
-
You are here:
